K-CONNECT 2025 MEETING

An exclusive event in Danang, Vietnam, bringing together leading oncologists and researchers from across the AsiaPacific region. K-CONNECT APAC 2025 aims to delve into the cutting-edge applications of ctDNA-MRD, share realworld experiences, and collaborate on pioneering advancements in precision oncology.

The event gathered over #100 distinguished oncologists and molecular biologists from nine Asia-Pacific countries, including #16 distinguished speakers, panelists, and chairs presented breakthrough research and clinical insights, fostering cross-border collaboration and inspiring new directions in cancer diagnostics and treatment. All were united in a shared mission: to explore the clinical potential of ctDNA-MRD, exchange real-world experiences, and drive innovation in genomic profiling and personalized oncology.

Days

Hours

Minutes

Seconds

The event has ended. Thank you for your participation.

K-CONNECT APAC 2025

EMPOWERING THE POTENTIAL OF ctDNA-MRD

Gene Solutions, JSC

Gene Solutions envisions elevating healthcare in Asia through multi-dimensional genomics and AI, committed to accessible genetic testing services.

LIBRARY

Clinical Utility of ctDNA-MRD in NSCLC: Real-World Insights and Case Applications

Speakers:

kconnect.genesolutions.com huy trinh le cac bs k connect 2026 08 - The K-CONNECT Platform

Vu Le Thuong

University Medical Center Ho Chi Minh City

Real-World Application of ctDNA-MRD in Early-Stage Lung Adenocarcinoma: Two Clinical Case Analyses

Speakers:

Sutima Luangdilok

Chulalongkorn University, Thailand

Personalizing NSCLC Follow-Up and Treatment with ctDNA-MRD: Lessons from Practice

Speakers:

Sita Laksmi Andarini

National Referral for Repiratory diseases, RSUP Persahabatan

Real-World Evidence for ctDNA-MRD in Breast Cancer Management

Speakers:

Pornchai O-Charoenrat 

Chaophya Hospital, Thailand

Harnessing ctDNA-MRD to Guide Complex Treatment Decisions in Advanced HER2+ Breast Cancer

Speakers:

Samuel Haryono

Siloam MRCCC, Jakarta, Indonesia

The value of liquid biopsy at each stage of cancer care

Speakers:

Nick Pavlakis

University of Sydney, Australia

AI powered multi-omics ctDNA for early cancer screening: Analytical, prospective and real-world evidence

Speakers:

Son Le Tran

Gene Solutions

ctDNA-MRD in Action: Current Applications to Emerging Horizons

Speakers:

Aaron Tan Chia-Ken

National Cancer Centre Singapore

Advanced AI-driven Biomarkers: Integration in Precision Oncology

Speakers:

kconnect.genesolutions.com huy trinh le cac bs k connect 2026 07 - The K-CONNECT Platform

Herbert Ho Fung Loong

The Chinese University of Hong Kong (CUHK)

Panel discussion and Q&A Bridging the gap in genomic insights across the Asia-Pacific region

Speakers:

Panel discussion and Q&A

Bridging the gap in genomic insights across the Asia-Pacific region

Largest Real – World Data of a MCED test in ASIA

Speakers:

kconnect.genesolutions.com auto draft image 1 - The K-CONNECT Platform

Nguyen Luu Hong Dang

Medical Genetics Institute, Vietnam

The Importance of ctDNA-MRD and CGP in Precision Oncology

Speakers:

Nick Pavlakis

University of Sydney, Australia

No downloads found!

Upcoming videos will be released shortly

AGENDA

| K-CONNECT APAC 2025

May 9

Day 01

Arrival at Danang

May 10

Day 02

Academic Program & Panel Discussion

08:30 – 09:15

Welcome Reception

09:15 – 09:20

Empowering the potential of ctDNA-MRD Launch

Professor

Mai Trong Khoa

Vice President, Vietnam Society for Oncology Immunotherapy, Vietnam

Gene Solutions Introduction
Opening Speech

09:20 – 10:20

K-CONNECT Academic Session

Professor

Nick Pavlakis

University of Sydney, Australia

The Importance of ctDNA-MRD and CGP in Precision Oncology

ctDNA-MRD assay standard requirements
Combination of CGP & MRD: potential value
Clinical applications of ctDNA-MRD

Doctor

Tu Ngoc Ly Lan

Principal Investigator, Gene Solutions

Unique Combination of Genomic & Transcriptomic Profiling with ctDNA-MRD Monitoring

Doctor

Nguyen Duy Sinh

Medical Oncologist, Oncology Medical Director, Gene Solutions

Key findings from Asia’s First Real-World Study of ctDNA-MRD Monitoring in Solid Tumors

Q&A session

10:20 – 10:30

Coffee Break

10:30 – 11:30

CRC Session: ctDNA-MRD Applications & Real-World Cases Sharing

Doctor

Rattiya Cheewakriangkrai

Chiangmai Ram Hospital, Thailand

Personalizing Therapy in Borderline Rectosigmoid Cancer with Real-Time MRD Tracking

Associate Professor

Nguyen Thi Minh Phuong

Hong Ngoc Hospital – Phuc Truong Minh, Vietnam

Real-Time Molecular Surveillance in Colorectal Cancer: Lessons from a Challenging Case

Q&A session

11:30 – 12:45

Lunch Break

12:45 – 13:45

Lung Cancer Session: ctDNA-MRD Applications & Real-World Cases Sharing

Associate Professor

Vu Le Thuong

University Medical Center Ho Chi Minh City

Clinical Utility of ctDNA-MRD in NSCLC: Real-World Insights and Case Applications

Associate Professor

Sutima Luangdilok

Chulalongkorn University, Thailand

Real-World Application of ctDNA-MRD in Early-Stage Lung Adenocarcinoma: Two Clinical Case Analyses

Associate Professor

Sita Laksmi Andarini

National Referral for Repiratory diseases, RSUP Persahabatan

Personalizing NSCLC Follow-Up and Treatment with ctDNA-MRD: Lessons from Practice

Q&A session

13:45 – 13:55

Coffee Break

13:55 – 14:55

Breast Cancer Session: ctDNA-MRD Applications & Real-World Cases Sharing

Professor

Pornchai O-Charoenrat 

Chaophya Hospital, Thailand

Real-World Evidence for ctDNA-MRD in Breast Cancer Management

Doctor

Samuel Haryono

Siloam MRCCC, Jakarta, Indonesia

Harnessing ctDNA-MRD to Guide Complex Treatment Decisions in Advanced HER2+ Breast Cancer

Q&A session

14:55 – 15:25

Next Landmark In Genomic Profiling & ctDNA

Professor

Feng-Ming (Spring) Kong

The University of Hong Kong

Genetic Testing Guided Personalized Immunotherapy in Refractory Solid Tumors: A Phase II Randomized Clinical Trial

MSc, BSc

Ida Deleskog Lindstroem

Global Medical Affairs Director, Gene Solutions

Triad of Impact– A Multi-omic Solution to Advance Precision Oncology Innovation

Q&A session

15:25 – 15:30

Closing Remarks

Saturday,

November 1,
2025

Asia Pacific Precision Oncology

Visit Asia Pacific Precision Oncology Conference ➔

SPEAKERS & PANELISTS

Professor

K-CONNECT 2025 MEETING

K-CONNECT APAC 2025

EMPOWERING THE POTENTIAL OF ctDNA-MRD

Gene Solutions, JSC

LIBRARY

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Upcoming videos will be released shortly

AGENDA

| K-CONNECT APAC 2025

Key findings from Asia’s First Real-World Study of ctDNA-MRD Monitoring in Solid Tumors

SPEAKERS & PANELISTS

CASE STUDIES

Source:

JCO Oncology Advances

Cancer type:

Lung Cancer

Source:

JCO Oncology Advances

Cancer type:

Lung Cancer

Source:

JCO Oncology Advances

Cancer type:

Lung Cancer

Source:

JCO Oncology Advances

Cancer type:

Lung Cancer

Source:

JCO Oncology Advances

Cancer type:

Colorectal Cancer

Source:

JCO Oncology Advances

Cancer type:

Breast Cancer

K-CONNECT APAC 2025